Siemens Healthineers and STORZ MEDICAL Plan Sales Partnership for Urology

Siemens HealthineersOn the occasion of the 70th annual congress of the German Society for Urology, DGU, Siemens Healthineers and STORZ MEDICAL have announced plans to enter into a sales partnership agreement. As part of their collaboration, the two companies plan to market each other's systems to give their customers, and their customers' patients, access to the latest technologies for diagnostic imaging in urology and non-invasive and minimally invasive therapy. The combination of mobile C-arms in the Cios family from Siemens Healthineers and the shock wave lithotripsy system MODULITH® SLK "inline" from STORZ MEDICAL is ideally suited for the removal of stones from the entire urinary tract using powerful extracorporeal shock wave lithotripsy (ESWL).

"Working with Siemens Healthineers, we can make our expertise in urology available to a broader range of customers and offer comprehensive solutions," says Dr. Gerold Heine, CEO of STORZ MEDICAL. "The planned agreement highlights the great importance of urology to both companies," affirms Peter Schardt, head of X-ray Products at Siemens Healthineers. "Together, we can facilitate access to the best possible diagnostic and therapy solutions for our customers and their patients."

Using ESWL enables the stones to be located with both X-rays and ultrasound. Shock waves - targeted ultrasound waves generated outside the body - are aimed directly at the renal or urinary calculi, which break into small fragments and can then be eliminated. This non-invasive procedure and the low rate of complications represent a major benefit for the patients, and make the procedure a preferred treatment approach in many cases. Siemens Healthineers and STORZ MEDICAL will make an innovative system combination comprising selected models of mobile C-arms in the Cios family and the ESWL system MODULITH® SLK "inline" available to urologists for this purpose in the future.

About Siemens Healthineers

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.

In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.7 billion and adjusted profit of €2.5 billion and has about 48,000 employees worldwide.

About STORZ MEDICAL

Established in 1987, STORZ MEDICAL AG is an independent partner company of the KARL STORZ Group. From their headquarters in Tägerwilen, on the Swiss side of Lake Constance right in the heart of Europe, STORZ MEDICAL develops innovative shock wave systems that meet the highest standards of precision. Medical specialists and patients all over the world know they can rely on the experience and expertise of STORZ MEDICAL.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...